Wells Fargo’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-23,677
| Closed | -$3.24M | – | 6772 |
|
|
2018
Q2 | $3.24M | Sell |
23,677
-406
| -2% | -$36.9K | ﹤0.01% | 3062 |
|
|
2018
Q1 | $1.9M | Buy |
24,083
+1,756
| +8% | +$130K | ﹤0.01% | 3423 |
|
|
2017
Q4 | $1.52M | Buy |
22,327
+5,310
| +31% | +$275K | ﹤0.01% | 3590 |
|
|
2017
Q3 | $684K | Buy |
17,017
+5,507
| +48% | +$212K | ﹤0.01% | 4117 |
|
|
2017
Q2 | $458K | Buy |
11,510
+931
| +9% | +$34.1K | ﹤0.01% | 4275 |
|
|
2017
Q1 | $341K | Buy |
10,579
+692
| +7% | +$17.3K | ﹤0.01% | 4498 |
|
|
2016
Q4 | $175K | Buy |
9,887
+4,527
| +84% | +$97.5K | ﹤0.01% | 4842 |
|
|
2016
Q3 | $125K | Buy |
5,360
+1,062
| +25% | +$24.1K | ﹤0.01% | 4774 |
|
|
2016
Q2 | $80K | Sell |
4,298
-739
| -15% | -$13.4K | ﹤0.01% | 4961 |
|
|
2016
Q1 | $92K | Buy |
5,037
+735
| +17% | +$11.8K | ﹤0.01% | 4892 |
|
|
2015
Q4 | $91K | Sell |
4,302
-910
| -17% | -$17.5K | ﹤0.01% | 4983 |
|
|
2015
Q3 | $96K | Buy |
5,212
+514
| +11% | +$12.8K | ﹤0.01% | 4918 |
|
|
2015
Q2 | $159K | Sell |
4,698
-3,075
| -40% | -$124K | ﹤0.01% | 4741 |
|
|
2015
Q1 | $374K | Buy |
7,773
+3,002
| +63% | +$136K | ﹤0.01% | 4120 |
|
|
2014
Q4 | $105K | Sell |
4,771
-98
| -2% | -$2.26K | ﹤0.01% | 4726 |
|
|
2014
Q3 | $92K | Sell |
4,869
-317,708
| -98% | -$7.58M | ﹤0.01% | 4692 |
|
|
2014
Q2 | $8.7M | Buy |
322,577
+32,780
| +11% | +$831K | ﹤0.01% | 1916 |
|
|
2014
Q1 | $9.38M | Buy |
289,797
+260,975
| +905% | +$8.48M | ﹤0.01% | 1843 |
|
|
2013
Q4 | $686K | Buy |
+28,822
| New | +$806K | ﹤0.01% | 3640 |
|
Wells Fargo's FMI Position: Q3 2018 in Review
Wells Fargo sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 23,677 shares — an estimated $3.24M sold.
Wells Fargo first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $9.38M in Q1 2014. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Wells Fargo reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Wells Fargo sold 23,677 Foundation Medicine, Inc. shares in Q3 2018, an estimated $3.24M.
- Wells Fargo first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 19 quarters.
- Wells Fargo's Foundation Medicine, Inc. position peaked at $9.38M in Q1 2014.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Wells Fargo's 13F filing for Q3 2018, filed 2 Nov 2018.